Skip to main content
Sumit Madan, MD, Oncology, Gilbert, AZ

Sumit Madan MD

Hematologic Oncology


Banner MD Anderson Cancer Center

Join to View Full Profile
  • Banner MD Anderson Cancer Center2946 E Banner Gateway DriveGilbert, AZ 85234

  • Phone+1 480-256-6444

  • Fax+1 480-256-3682

Dr. Madan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2011 - 2014
  • Mayo Clinic College of Medicine
    Mayo Clinic College of MedicinePost-Doctoral Fellowship, 2009 - 2011
  • Rush University Medical Center
    Rush University Medical CenterFellowship, Hospice and Palliative Medicine, 2007 - 2008
  • Atlantic Health System/Overlook Medical Center
    Atlantic Health System/Overlook Medical CenterResidency, Internal Medicine, 2004 - 2007
  • Rajah Muthiah Medical College
    Rajah Muthiah Medical CollegeClass of 2002

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2018 - 2026
  • TX State Medical License
    TX State Medical License 2014 - 2023
  • MN State Medical License
    MN State Medical License 2008 - 2012
  • NJ State Medical License
    NJ State Medical License 2005 - 2009
  • IL State Medical License
    IL State Medical License 2007 - 2008
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Harpoon Therapeutics : ASH2022 Interim Clinical
    Harpoon Therapeutics : ASH2022 Interim ClinicalDecember 12th, 2022
  • Acetylon Presents Data on the Use of HDAC6 Inhibitors Ricolinostat (ACY-1215) and ACY-241 in Combination with Pomalidomide and Dexamethasone for the Treatment of Multiple Myeloma
    Acetylon Presents Data on the Use of HDAC6 Inhibitors Ricolinostat (ACY-1215) and ACY-241 in Combination with Pomalidomide and Dexamethasone for the Treatment of Multiple MyelomaJune 13th, 2016

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: